Skip to content

BioAdaptives Inc.: 10-Q filed 2019-08-14

What BioAdaptives Inc. reported in its quarterly report filed 2019-08-14 (fiscal Q2 2019): 23 published measures, 62 facts as tagged in accession 0001640334-19-001635.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-14
Fiscal period
fiscal Q2 2019
Accession
0001640334-19-001635 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioAdaptives Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-3021,289USD
At 2018-12-31110,059USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-30760,456USD
At 2018-12-31803,800USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-30-739,167USD
At 2019-03-31-580,296USD
At 2018-12-31-693,741USD
At 2018-06-30-315,293USD
At 2018-03-3126,406USD
At 2017-12-313,505USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-3011,866USD
At 2018-12-3156,215USD
At 2018-06-30180,511USD
At 2017-12-31360USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-179,871USD91
2019-01-01 to 2019-06-30-87,426USD181
2019-01-01 to 2019-03-3192,445USD90
2018-04-01 to 2018-06-30-412,775USD91
2018-01-01 to 2018-06-30-421,874USD181
2018-01-01 to 2018-03-31-9,099USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-59,349USD181
2018-01-01 to 2018-06-30-167,849USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-3015,000USD181
2018-01-01 to 2018-06-30316,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-01-01 to 2018-06-3032,000USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-4,607,416USD
At 2018-12-31-4,519,990USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-01-01 to 2018-06-3014,650USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-3021,289USD
At 2018-12-31110,059USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-04-01 to 2019-06-3048,597USD91
2019-01-01 to 2019-06-3097,578USD181
2018-04-01 to 2018-06-3023,065USD91
2018-01-01 to 2018-06-3023,065USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-30742,121USD
At 2018-12-31715,989USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-04-01 to 2019-06-3041,948USD91
2019-01-01 to 2019-06-30108,615USD181
2018-04-01 to 2018-06-30258,412USD91
2018-01-01 to 2018-06-30266,846USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-307,720USD
At 2018-12-3149,857USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-303,687USD91
2019-01-01 to 2019-06-304,879USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-3018,096,169shares
At 2018-12-3118,096,169shares

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-179,871USD91
2019-01-01 to 2019-06-30-87,426USD181
2018-04-01 to 2018-06-30-412,775USD91
2018-01-01 to 2018-06-30-421,874USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-3014,592USD91
2019-01-01 to 2019-06-3024,359USD181
2018-04-01 to 2018-06-3066,147USD91
2018-01-01 to 2018-06-3068,771USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-141,610USD91
2019-01-01 to 2019-06-3016,310USD181
2018-04-01 to 2018-06-30-154,363USD91
2018-01-01 to 2018-06-30-155,028USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-06-3018,260USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2019-01-01 to 2019-06-300USD181
2018-01-01 to 2018-06-300USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-42,137USD181

Inspect the source

Entity
BioAdaptives Inc. / CIK 0001575142
Captured
2026-09-20T09:21:44.555Z
SEC response SHA-256
7d70ec2a8370eeb33cd7c2482065b30cf052619c39bb59e21df838c8d2f96db2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))